{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:39:26Z","timestamp":1779176366924,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.mehy.2008.08.025","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T08:08:37Z","timestamp":1226304517000},"page":"220-222","source":"Crossref","is-referenced-by-count":12,"title":["Parasitic brain infection, endocannabinoids, and schizophrenia"],"prefix":"10.1016","volume":"72","author":[{"given":"Robert","family":"Melamede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2008.08.025_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/00048670801961156","article-title":"Cannabis, cannabinoids and schizophrenia: integration of the evidence","volume":"42 5","author":"Cohen","year":"2008","journal-title":"Aust NZ J Psychiat"},{"key":"10.1016\/j.mehy.2008.08.025_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","author":"D\u2019souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2008.08.025_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2008.02.003","article-title":"Long lasting consequences of cannabis exposure in adolescence","author":"Rubino","year":"2008","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.mehy.2008.08.025_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YCO.0b013e3280fa838e","article-title":"Cannabis use and psychiatric and cognitive disorders: the chicken or the egg?","volume":"20","author":"Di Forti","year":"2007","journal-title":"Curr Opin Psychiat"},{"key":"10.1016\/j.mehy.2008.08.025_bib5","first-page":"1669","article-title":"Endocannabinoids: multi-scaled, global homeostatic regulators of cells and society","author":"Melamede","year":"2006","journal-title":"InterJ Complex Syst"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","article-title":"Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system","volume":"56","author":"Emrich","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.mehy.2008.08.025_bib7","first-page":"880","article-title":"Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14\u2013q15","volume":"3","author":"Hoehe","year":"1991","journal-title":"New Biol"},{"issue":"1","key":"10.1016\/j.mehy.2008.08.025_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1997.4815","article-title":"Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees","volume":"43","author":"Cao","year":"1997","journal-title":"Genomics"},{"issue":"10","key":"10.1016\/j.mehy.2008.08.025_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene \u00d7 environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.mehy.2008.08.025_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.107.036129","article-title":"Genotype effects of chrna7, cnr1 and comt in schizophrenia: interactions with tobacco and cannabis use","volume":"191","author":"Zammit","year":"2007","journal-title":"Brit J Psychiat"},{"issue":"6","key":"10.1016\/j.mehy.2008.08.025_bib11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2008.08.025_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.mehy.2008.08.025_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/0269881107083816","article-title":"Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy","author":"Potvin","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"6441","key":"10.1016\/j.mehy.2008.08.025_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mehy.2008.08.025_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10425179509020870","article-title":"Cloning and sequencing of a cdna encoding the mouse brain-type cannabinoid receptor protein","volume":"5","author":"Chakrabarti","year":"1995","journal-title":"DNA Seq"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2008.08.025_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/MN:26:2-3:317","article-title":"Acute neuronal injury, excitotoxicity, and the endocannabinoid system","volume":"26","author":"Van Der Stelt","year":"2002","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.mehy.2008.08.025_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-4781(96)00047-4","article-title":"Molecular cloning, expression and function of the murine cb2 peripheral cannabinoid receptor","volume":"1307","author":"Shire","year":"1996","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/j.mehy.2008.08.025_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bjp.0707527","article-title":"The peripheral cannabinoid receptor knockout mice: an update","volume":"153","author":"Buckley","year":"2008","journal-title":"Brit J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2008.08.025_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0707617","article-title":"Cb(2) cannabinoid receptors: new vistas","volume":"153","author":"Mackie","year":"2008","journal-title":"Brit J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2567.1997.00290.x","article-title":"Interleukin-10 modulates susceptibility in experimental cerebral malaria","volume":"91","author":"Kossodo","year":"1997","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.mehy.2008.08.025_bib21","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.4049\/jimmunol.151.9.4811","article-title":"Profiles of cytokine production in relation with susceptibility to cerebral malaria","volume":"151","author":"De Kossodo","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2008.08.025_bib22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1189\/jlb.0405216","article-title":"Cannabinoid receptors in microglia of the central nervous system: immune functional relevance","volume":"78","author":"Cabral","year":"2005","journal-title":"J Leukocyte Biol"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2008-13402","article-title":"Inflammatory aspects of alzheimer disease and other neurodegenerative disorders","volume":"13","author":"Schwab","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.mehy.2008.08.025_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chom.2008.01.001","article-title":"Toxoplasma profilin is essential for host cell invasion and tlr11-dependent induction of an interleukin-12 response","volume":"3","author":"Plattner","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2008.08.025_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"Delta 9-tetrahydrocannabinol regulates th1\/th2 cytokine balance in activated human t cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.schbul.a033407","article-title":"At issue: schizophrenia and rheumatoid arthritis: the negative association revisited","volume":"25","author":"Oken","year":"1999","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/brbi.2001.0649","article-title":"The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?","volume":"15","author":"Torrey","year":"2001","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2008.08.025_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.09.014","article-title":"Il-17\/th17 targeting: on the road to prevent chronic destructive arthritis?","volume":"41 2","author":"Lubberts","year":"2008","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.mehy.2008.08.025_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.mehy.2008.08.025_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.mehy.2008.08.025_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during cns inflammation by induction of mkp-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770800491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770800491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T23:24:35Z","timestamp":1684625075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698770800491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S030698770800491X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2008.08.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}